Breakfast Industry Symposium:
Sharing clinical experience with eligible women with HR+/HER2- advanced breast cancer – interactive case studies and panel discussions
This promotional symposium has been organised and funded by Novartis Pharmaceuticals UK Ltd.
Novartis products will be discussed at this symposium and prescribing information will be available from a Novartis representative during the symposium

Thursday, September 12, 2024
07:30-08:30
HALL B
Light refreshments will be served prior to the session from 7:00

Chairperson: Marina Parton,  London, UK
07:30-07:50 Case Study – an older adult with advanced breast cancer
Alistair Ring, London, UK
07:50-08:10 Case Study – an advanced breast cancer patient with cardiac co-morbidities
Olga Oikonomidou,  Edinburgh, Scotland, UK
08:10-08:30 Case Study – an advanced breast cancer patient with visceral metastasis
Mark Verrill, Newcastle upon Tyne, UK

UK I August 2024 I FA-11253802

Skip to content